among these are several telaprevir abstracts, the itmn-191/ritonavir boosting study (which looks good btw), data on a couple of impressive PIs for HCV (one clinical with high potentcy from BI, another preclinical from MRK), and plenty on IL-28b polymorphisms I'm sure there are others of interest - i didn't have time for more than a quick scan..
Market Data 
Markets 
AI
